Company News in the Life Science Industry

»

Reset 

Early Adopters in Germany and the United Kingdom Are Prescribing Merck KGaA's Mavenclad as First-Line Induction Therapy for the Treatment of Multiple Sclerosis

EXTON, Pa., Nov. 21, 2017 /PRNewswire/ -- The multiple sclerosis (MS) market in the EU is poised to become even more fiercely competitive with the August 2017 approval of Merck KGaA's Mavenclad (cladribine) and imminent approval of Roche's Ocrevus (ocrelizumab). In a new report by Spherix Global... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017

Innovaccer Deploys CIS(TM) Product Suite at StratiFi Health

SAN FRANCISCO, Nov. 21, 2017 /PRNewswire/ -- StratiFi Health, a physician services and population health organization, is further advancing their population health management initiatives in partnership with Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017

Probiotics and Prebiotics Food and Beverage New Product Trends 2017 - Cutting Edge, Taking Root & Going Mainstream

DUBLIN, November 21, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Neurocrine Biosciences to Present at the 29th Annual Piper Jaffray Healthcare Conference

SAN DIEGO, Nov. 21, 2017 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the 29th Annual Piper Jaffray Healthcare Conference at 12:00 p.m. ET on Tuesday, Nov. 28, 2017, in New York City. Timothy P. Coughlin, Vice President Finance of Neurocrine Biosciences, will present... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Neurocrine Biosciences, Inc.

Recent Chart Audit Reveals Switching Rheumatoid Arthritis Patients to Roche/Genentech's RoActemra (Actemra) is Significantly More Common in the EU5 than it is in the US

EXTON, Pa., Nov. 21, 2017 /PRNewswire/ -- Analysis of over 2,200 RA patients in the US and EU5 (France, Germany, Italy, Spain, and the United Kingdom) reveals clear differentiation in treatment patterns amongst rheumatoid arthritis (RA) patients who have recently switched brands. US rheumatologists... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017

SCRS Welcomes New Global Impact Partner, CPi Global CRO

ELLICOTT CITY, Md., Nov. 21, 2017 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) announced today that CPi Global CRO has joined the organization as a Global Impact Partner (GIP). SCRS' GIP Program provides a unique opportunity for sponsors, CROs and vendors to engage with SCRS... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017

FDA approves first two-drug regimen for certain patients with HIV

SILVER SPRING, Md., Nov. 21, 2017 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs included... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  U.S. Food and Drug Administration

Takeda's Entyvio Defends Share Against Janssen's Stelara in the Crohn's Disease Market, and Pressure in the Ulcerative Colitis Market May Heat Up in Early 2018 if Pfizer's Xeljanz Secures an FDA Win

EXTON, Pa., Nov. 21, 2017 /PRNewswire/ -- A survey of over 100 US gastroenterologists fielded in late October 2017 indicates that, in both the ulcerative colitis (UC) and Crohn's Disease (CD) markets, the established TNF inhibitors, Remicade and AbbVie's Humira, persistently dominate biologic... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017

New Report Explores how Medical Device Industry can Utilize a Value-Selling Approach to Survive in the Emerging Sales Landscape

CHAPEL HILL, N.C., Nov. 21, 2017 /PRNewswire/ -- To meet the challenges of an evolving marketplace marked by consolidation and the increasing power of payers and provider networks, medical device sales organizations are shifting to a sales approach that demonstrates value to a wide range of customers.

... Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017

Novus Therapeutics to Present at the 29th Annual Piper Jaffray Healthcare Conference

IRVINE, California, Nov. 21, 2017 /PRNewswire/ -- Novus Therapeutics, Inc. (NASDAQ: NVUS), a development stage specialty pharmaceutical company focused on the development of products for disorders of the ear, nose, and throat (ENT), announced today that Gregory J. Flesher, Chief Executive Officer,... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Novus Therapeutics, Inc.

DelMar Presents Positive Interim Results from VAL-083 Study in MGMT-unmethylated Recurrent GBM at The Society for NeuroOncology Annual Meeting

VANCOUVER, British Columbia and MENLO PARK, Calif., Nov. 21, 2017 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new cancer... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017

Medtronic Reports Second Quarter Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  Medtronic Plc

Auris Medical News Release

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  Auris Medical AG

CrownBio's Translatable FATZO Model Utilized in Eli Lilly's Preclinical Type 2 Diabetes Research Programs

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  Hisamitsu Pharmaceutical Co., Inc.

Modex adds top advisor from Google

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017

AC Immune to Host Key Opinion Leader Meeting on Tau as a Therapeutic and Diagnostic Target in Alzheimer's and other Neurodegenerative Diseases

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  AC Immune SA

RESULTS FROM THE PHASE III HERCULES STUDY OF CAPLACIZUMAB FOR THE TREATMENT OF ACQUIRED TTP SELECTED FOR PRESENTATION IN THE LATE-BREAKING ABSTRACTS SESSION AT THE 2017 ASH ANNUAL MEETING

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  Ablynx N.V.

Vascular Flow Technologies Forges Strategic Partnership With Biovic to Develop the New Avatar SLF(TM) Vascular Graft

DUNDEE, Scotland, November 21, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017

Alligator Bioscience AB Presents at Redeye Life Science Seminar 24 November 2017

LUND, Sweden, Nov. 21, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Alligator Bioscience AB

NAFLD/NASH Diagnosis is Unexpected to People Not Aware of This Rising Epidemic

LONDON, Nov. 21, 2017 /PRNewswire/ -- If like many of us you are planning to feast on a huge roast turkey dinner this Thanksgiving, you might want to check your portion size. A market research study recently conducted by global agency Research Partnership among US patients with NAFLD/NASH reveals... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Cambridge Design Partnership LLP | Strategy Foresight Partnership LLP | The Pathology Partnership | The IP Asset Partnership Limited
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 40,000 companies